JPRN-jRCTb040190122
Recruiting
Phase 2
Efficacy of cultured epidermal autograft in the treatment of vitiligo, refractory scar and refractory skin ulcer. - Efficacy of cultured epidermal autograft for skin disease
Toriyama Kazuhiro0 sites60 target enrollmentMarch 2, 2020
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- vitiligo, refractory scar and refractory skin ulcer
- Sponsor
- Toriyama Kazuhiro
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) The person who has vitiligo, refractory scar and refractory skin ulcer more than six months
- •(2\) The person who understand and consent this clinical trial. The necessity of written consent by legal representatives (parents, guardians) as well as by the principal when the person is restricted in the age (from 16 to 20\). Additionally, The necessity of written consent by legal representatives (parents, guardians) when the person is under 16 year od age.
- •(3\) Negative in the prescribed infection inspection (hepatitis B, hepatitis C, syphilis, human immunodeficincy virus, adult T cell leukemia)
Exclusion Criteria
- •(1\) Allergy to antibiotic (penicillin, kanamycin, streptomycin, amphotericin B), medical history of allergy to penicillins and aminoglycoside.
- •(2\) Allergy to animals (cow, mouse, pig)
- •(3\) Suspected , present illness and medical history of skin malignant tumor
- •(4\) Difficulty of participation due to mental disorder
- •(5\) Pregnant, lactating woman and possibility of pregnancy
- •(6\) Skin Infectious disease requiring systemic medical treatment
- •(7\) Positive in the prescribed infection inspection (hepatitis B, hepatitis C, syphilis, human immunodeficincy virus, adult T cell leukemia)
- •(8\) Not suitable for this clinical trial from the view oint of the doctors who perform regenerative medicine
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Efficacy of cultured epidermal autograft in vitiligo, refractory scar and refractry skin culcer.vitiligo, refractory scar, refractory skin ulcerJPRN-UMIN000027915agoya City University60
Recruiting
Phase 3
The efficacy of topical recombinant human epidermal growth factor gel in combination with fractional radiofrequency microneedle in the treatment of mild to moderate atrophic acne scarmild to moderate rolling and shallow boxcar acne scarsTCTR20201201003none20
Not yet recruiting
Phase 4
Healing of mouth soft tissues using topically applied gel.CTRI/2023/01/049177OFFICE OF DGDS
Recruiting
Not Applicable
se of Acellular Human Dermal Allograft Patch for Augmentation of Rotator Cuff Repair - A Randomised Controlled TrialACTRN12623001350617St. John of God Healthcare Subiaco40
Not yet recruiting
Not Applicable
Evaluation of use of human donor skin grafts in treating burn wounds.Health Condition 1: T300- Burn of unspecified body region, unspecified degreeCTRI/2021/01/030558Dr Annappa Kudva